DFX Intelligence
Venture Capital Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Companies / A••••••• I•••
A••••••• I•••
Stage unknownCambridge, MAPharmaceuticals
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 2
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 0
Financing history
2 rounds
- Mar 11, 2026Form D equity offering · $25.0M (form d sold) · 2 investorsFact SEC EDGAR Form D data sets (quarterly) · “A••••••• I••• filed Form D: $24,999,994 sold of $24,999,994, Pharmaceuticals”
- Apr 23, 2025Form D equity offering · $16.5M (form d sold) · 3 investorsFact SEC EDGAR Form D data sets (quarterly) · “A••••••• I••• filed Form D: $16,499,982 sold of $16,499,982, Pharmaceuticals”
Investors on record
0 edges
No named investor yet.
People
4 officers, 7 directors
- B•••• G• W••• Executive Officer sec.gov
- D••••• G• M••••• Executive Officer sec.gov
- L••••••• G• M••••• Executive Officer/Director sec.gov
- R•••• C• B•••••• Executive Officer sec.gov
- F••••••• C• B••••••• Director Fact
- I•••• C• C•••• Director Fact
- P••• C• F••••••• Director Fact
- K•••• C• L••• Director Fact
- G••• C• S••••• Director Fact
- J••••• C• A••••••• Director Fact
- C•••• C• D••••••••• Director Fact
Timeline
2
- Mar 27, 2026A••••••• I••• filed Form D: $24,999,994 sold of $24,999,994, PharmaceuticalsForm D filed Fact SEC EDGAR Form D data sets (quarterly)
- Apr 24, 2025A••••••• I••• filed Form D: $16,499,982 sold of $16,499,982, PharmaceuticalsForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
29 observations
Every observation on this company
- Entity type: Corporation Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Corporation Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Pharmaceuticals Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Pharmaceuticals Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $25.0M Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $16.5M Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $25.0M Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $16.5M Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2026-03-11 Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2025-04-23 Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 2 Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 3 Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 39 JOHN F. KENNEDY STREET, 4TH FLR., CAMBRIDGE, MA, 02138 Mar 27, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 39 JOHN F. KENNEDY STREET, 4TH FLR., CAMBRIDGE, MA, 02138 Apr 24, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Round announced: Debt Financing $150,000,000 Apr 6, 2026 Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)